J&J expects to deliver 20 mln doses in U.S. by end of March

The single-dose vaccine is being considered by an outside advisory committee to the U.S. Food and Drug Administration later this week, and emergency use authorization could come shortly afterward.

Nettles also said Johnson & Johnson expects to be able to ship nearly 4 million doses of its COVID-19 vaccine upon authorization in the U.S.